Odyssey Health (ODYY) Shares Outstanding (2014 - 2026)
Odyssey Health (ODYY) posted quarterly Shares Outstanding (Entity) of $101.0 million for Q2 2026, up 4.4% year-over-year from $96.7 million in Q2 2025, and up 1.12% quarter-over-quarter from $99.9 million in Q1 2026.
Odyssey Health (ODYY) Shares Outstanding (2014 - 2026) Analysis & Trends
Odyssey Health's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $101.0 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 4.4% year-over-year to $101.0 million; the TTM figure through Apr 2026 stood at $101.0 million (up 4.4% YoY), while the FY2025 annual figure was $96.7 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $101.0 million, up from $99.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $101.0 million in Q2 2026, with the low at $72.0 million in Q4 2022.
- The 5-year median for Shares Outstanding (Entity) is $95.4 million (2024), against an average of $89.2 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) fell 20.9% in 2022, then gained 24.57% in 2024.
- Odyssey Health's Shares Outstanding (Entity) stood at $72.0 million in 2022, then gained by 13.53% to $81.7 million in 2023, then grew by 18.32% to $96.7 million in 2024, then gained by 3.25% to $99.9 million in 2025, then increased by 1.12% to $101.0 million in 2026.
- Business Quant data shows ODYY's Shares Outstanding (Entity) at $101.0 million in Q2 2026, $99.9 million in Q1 2026, and $99.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 108.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 108.03 Mn |
| Jan 31, 2026 | 107.85 Mn |
| Oct 31, 2025 | 106.04 Mn |
| Jul 31, 2025 | 104.71 Mn |
| Apr 30, 2025 | 104.71 Mn |
| Jan 31, 2025 | 104.71 Mn |
| Oct 31, 2024 | 104.71 Mn |
| Jul 31, 2024 | 97.06 Mn |
| Apr 30, 2024 | 103.79 Mn |
| Jan 31, 2024 | 91.98 Mn |
| Oct 31, 2023 | 81.02 Mn |
| Jul 31, 2023 | 82.68 Mn |
| Apr 30, 2023 | 83.16 Mn |
| Jan 31, 2023 | 81.78 Mn |
| Oct 31, 2022 | 80.89 Mn |
| Jul 31, 2022 | 89.00 Mn |
| Apr 30, 2022 | 83.95 Mn |
| Jan 31, 2022 | 91.62 Mn |
| Oct 31, 2021 | 88.06 Mn |
| Jul 31, 2021 | 93.73 Mn |